Pulmonology

General Infectious Disease

Questions discussed in this category

What factors do you consider when deciding between monotherapy with an antipseudomonal cephalosporin and combination therapy in ICU patients with Pseudomonas aeruginosa bloodstream infection who are not in septic shock?

Bavaro et al., PMID 40088112

1 Answer available

Do you treat complicated pneumonia with a drained empyema longer if Streptococcus anginosus is cultured, either in isolation or with other organisms, compared to cases in which it is not?

1 Answer available

What is your approach to a patient with undetectable MMR titers checked prior to or during immunosuppression and a history of MMR vaccination in childhood?

Is there a role for booster vaccination and if so, how do you approach the timing when a patient is already on a biologic for immunosuppression?

1 Answer available

How do you decide on the timing and number of blood cultures for suspected endocarditis given the differences in recommendations between the ESC guidelines and the Duke Criteria?

The ESC guidelines recommend obtaining at least three sets of blood cultures at 30-minute intervals before starting antibiotic therapy, each with 10 m...

4 Answers available

In light of recent measles outbreaks in the US, would you recommend an MMR booster for an immunocompetent patients born before 1957?

6 Answers available

What are your vaccine recommendations while patients are on biologics?

2 Answers available

Is there a specific criteria that you use to determine if a patient with respiratory symptoms should have a multiplex respiratory test performed?

1 Answer available

Would you consider antifungal prophylaxis for immunocompromised patients with COVID-19 requiring mechanical ventilation, considering the high risk of invasive pulmonary aspergillosis in patients with severe COVID-19?

Feys et al., PMID 37691392

1 Answer available

Do you recommend treating Candida albicans on urine culture from an indwelling catheter in a patient with septic shock?

3 Answers available

Which biomarkers or diagnostic tools do you prioritize to support the decision to start antifungal treatment in septic patients with no clear source of infection but at high risk for fungal infections?

4 Answers available

Are there situations where you would consider treating E faecalis or E faecium that grows from a respiratory culture?

1 Answer available

What duration of antibiotic therapy do you use for a loculated parapneumonic effusion that does not meet criteria for empyema?

6 Answers available

What is your approach to treatment of patients with fulminant C difficile infection who required ileostomy creation or colectomy?

Is there a role for oral vancomycin in these patients, or is oral vancomycin redundant if other routes of administration are being used (i.e intracolo...

1 Answer available

Have you incorporated the use of linezolid in lieu of vancomycin plus clindamycin for empiric treatment of necrotizing fasciitis?

1 Answer available

How do you manage resistant infections that persist after stopping antibiotic therapy in patients with non-CF bronchiectasis?

1 Answer available

Is there any utility to trending Histoplasma serology titers to guide duration of therapy or treatment response for pulmonary histoplasmosis with negative urine antigen?

2 Answers available

Do you recommend procalcitonin to help convince other providers to stop antibiotics in patients with pneumonia in whom a non-infectious diagnosis is strongly suspected?

2 Answers available

What is your approach to the use of Paxlovid for patients with risk factors for severe Covid-19 infection but who have received SARS-CoV-2 vaccines in light of the EPIC-SR trial findings?

EPIC-SR Trial

3 Answers available